GNH USA

Europe — EMA

Meropenem Acs Dobfar (Meropenem Anhydrous)

GNH USA supplies Meropenem Acs Dobfar (Meropenem), a carbapenem antibiotic for complicated intra‑abdominal infections, pneumonia, meningitis and severe

Meropenem Anhydrous

Request sourcing

1
Pack/s

What is Meropenem Anhydrous?

Meropenem, the active ingredient in Meropenem Acs Dobfar, is a carbapenem antibiotic presented as an IV solution for intravenous use. It treats severe bacterial infections such as complicated intra‑abdominal infections, urinary tract infections, pneumonia, meningitis, and sepsis in hospitalized patients.

GNH USA supplies Meropenem Acs Dobfar as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres and pharmacies worldwide.

What is Meropenem Anhydrous used for?

Meropenem is a carbapenem antibiotic used to treat serious bacterial infections across several organ systems.

- Complicated intra‑abdominal infections: provides rapid bacterial eradication in patients with intra‑abdominal sepsis. - Complicated urinary tract infections: clears resistant uropathogens causing severe UTIs. - Nosocomial pneumonia: effective against hospital‑acquired lung infections. - Community‑acquired pneumonia: treats severe community‑origin bacterial pneumonia. - Meningitis: penetrates the cerebrospinal fluid to combat bacterial meningitis. - Severe sepsis: broad‑spectrum activity supports management of systemic infection.

What are the side effects of Meropenem Anhydrous?

Adverse reactions may occur with meropenem therapy.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: may be watery and self‑limiting. - Vomiting: occasional emesis during infusion. - Headache: transient headache reported. - Infusion site reactions: erythema or phlebitis at the injection site. - Elevated liver enzymes: transient increase in transaminases.

Serious or Rare Side Effects: - Seizures: risk increased in patients with renal impairment or CNS disorders. - Severe allergic reactions: anaphylaxis or Stevens‑Johnson syndrome. - Clostridioides difficile colitis: possible severe diarrhea. - Renal impairment: acute kidney injury in susceptible individuals. - Thrombocytopenia: low platelet counts requiring monitoring. - Anaphylaxis: immediate hypersensitivity requiring emergency care.

What precautions apply to Meropenem Anhydrous?

Careful assessment and monitoring are required when using meropenem. - Renal function: adjust dose in patients with impaired renal clearance. - Seizure risk: monitor patients with a history of CNS disorders. - Allergy: avoid in individuals with known hypersensitivity to carbapenems. - Pregnancy: use only if the potential benefit justifies the potential risk to the fetus. - Drug interactions: review concomitant medications for potential interactions. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

What does Meropenem Anhydrous interact with?

Meropenem may interact with several concomitant medications.

Major Interactions (Avoid): - Valproic acid: may reduce serum levels, increasing seizure risk. - Cisplatin: combined use can enhance nephrotoxicity. - Probenecid: may increase meropenem plasma concentrations. - Other β‑lactam antibiotics: potential antagonistic effects.

Moderate Interactions (Monitor Closely): - Aminoglycosides: additive nephrotoxic potential. - Loop diuretics: may affect renal clearance of meropenem. - Warfarin: monitor INR for possible anticoagulant effect changes.

Frequently asked questions

What infections is Meropenem Acs Dobfar used for?+
Meropenem Acs Dobfar is indicated for the treatment of serious bacterial infections such as complicated intra‑abdominal infections, complicated urinary tract infections, hospital‑acquired and community‑acquired pneumonia, bacterial meningitis, and severe sepsis. It is typically reserved for patients who require broad‑spectrum coverage in a hospital setting.
How does meropenem work to fight bacteria?+
Meropenem exerts its antibacterial effect by binding to penicillin‑binding proteins on the bacterial cell wall, blocking the cross‑linking of peptidoglycan strands. This inhibition prevents cell‑wall synthesis, leading to osmotic instability and bacterial cell death. Its structure also confers resistance to many β‑lactamases, expanding its activity against resistant organisms.
What is the usual dose of Meropenem Acs Dobfar?+
The dosing regimen for Meropenem Acs Dobfar is determined by the prescribing clinician based on the type and severity of infection, renal function, and patient weight. Healthcare professionals calculate the appropriate intravenous infusion rate and duration according to established clinical guidelines.
Is Meropenem safe to use during pregnancy or breastfeeding?+
Safety data for meropenem in pregnancy and lactation are limited. The drug should be used only if the potential benefit to the mother outweighs any possible risk to the fetus or infant. Clinicians should discuss the risk‑benefit profile with the patient and consider alternative therapies when appropriate.
How do I order Meropenem Acs Dobfar from GNH USA?+
To place an order, visit the product page on gnh-usa.com, enter the required quantity, and submit the enquiry form. GNH USA supplies hospitals, pharmacies and procurement teams worldwide. After submission, the sales team will verify trade or institutional credentials and respond with pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.
How does Meropenem compare with other carbapenems?+
Meropenem shares a similar spectrum with other carbapenems such as imipenem and ertapenem but offers broader activity against Pseudomonas aeruginosa and certain resistant Gram‑negative organisms. It is also more stable against many β‑lactamases. Choice among carbapenems depends on infection type, pathogen susceptibility, patient renal function, and safety considerations.
What are the storage and handling requirements for Meropenem Acs Dobfar?+
Meropenem Acs Dobfar should be stored at 2‑8 °C in a refrigerator, protected from light, and must not be frozen. Once reconstituted, the solution should be used within the time frame specified by the manufacturer and kept under the same temperature conditions during administration.
How is Meropenem Acs Dobfar administered?+
The product is supplied for intravenous infusion. It is typically diluted in an appropriate compatible solution and administered over a prescribed period, often 30 minutes to 1 hour, depending on the clinical protocol. Administration should be performed by qualified healthcare personnel in a controlled setting.
What are the most serious risks associated with Meropenem therapy?+
The most serious adverse events include seizures, especially in patients with renal impairment or pre‑existing CNS disorders, severe hypersensitivity reactions such as anaphylaxis, and Clostridioides difficile‑associated colitis. Clinicians should monitor patients closely for neurological changes, allergic signs, and persistent diarrhea.
Who should not receive Meropenem Acs Dobfar?+
Meropenem is contraindicated in individuals with a known hypersensitivity to meropenem, other carbapenems, or any component of the formulation. Caution is also advised for patients with a history of seizures, severe renal impairment, or those receiving interacting medications that could increase toxicity.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Meropenem Anhydrous
Route
Intravenous Use
Manufacturer
Acs Dobfar S.P.A.
Origin
EU

Related products

Agenor

Agenor

Meropenem Anhydrous

Medochemie Ltd.
EU
Agenorem

Agenorem

Meropenem Anhydrous

Medochemie Ltd.
EU
Archifar

Archifar

Meropenem Anhydrous

Medochemie Ltd.
EU
Archifar

Archifar

Meropenem Anhydrous

Medochemie Ltd.
EU